EpicentRx
  • Vision
    • Culture
    • Team
  • Pipeline
  • Technologies
    • AdAPT™ Platform
    • PRETECT™ Platform (RRx-001)
  • News
    • Press Releases
    • Media
    • Conferences
    • Newsletter
  • Blog
  • Careers
  • Contact Us
Select Page
EpicentRx To Present Nibrozetone (RRx-001) Data on Parkinson’s Disease and ALS/MND at Neuroscience 2023

EpicentRx To Present Nibrozetone (RRx-001) Data on Parkinson’s Disease and ALS/MND at Neuroscience 2023

by EpicentRx | Nov 6, 2023 | 2023, Press Releases

TORREY PINES, Calif., Nov. 6, 2023 /PRNewswire/ — EpicentRx, Inc. (“EpicentRx”), a clinical-stage biotechnology company with two therapeutic platforms that address cancer and inflammatory diseases, has been selected for oral and poster presentations...
No “Fall” in Activity for EpicentRx After Summer

No “Fall” in Activity for EpicentRx After Summer

by EpicentRx | Nov 1, 2023 | Company Updates

A busy Fall “leaves” little to no downtime for EpicentRx Summer slowdown? What summer slowdown? EpicentRx kicked off the Fall season in high gear with continuing preparations for the start of a large Phase 2b follow on study called KEVLARx with nibrozetone (RRx-001)...
EpicentRx To Present Nibrozetone (RRx-001) Data on Parkinson’s Disease and ALS/MND at Neuroscience 2023

Partnering with EpicentRx

by EpicentRx | Oct 19, 2023 | Media

EpicentRx To Present Nibrozetone (RRx-001) Data on Parkinson’s Disease and ALS/MND at Neuroscience 2023

Oncolytic Virotherapy Summit 2023

by EpicentRx | Sep 25, 2023 | Conferences

December 2023; Boston, MA Oral Presentation: Evaluating the Advantages & Hurdles of Intratumoral Delivery of Oncolytic Viruses
EpicentRx To Present Nibrozetone (RRx-001) Data on Parkinson’s Disease and ALS/MND at Neuroscience 2023

Severe Oral Mucositis: Companies Put Their Money where the Mouth is and Vie for a Marketshare

by EpicentRx | Sep 11, 2023 | Media

« Older Entries
858.947.6635
11099 North Torrey Pines Road
Suite 160
La Jolla, CA 92037
Follow Us
  • Follow
  • Follow
Subscribe to our newsletter

This field is for validation purposes and should be left unchanged.

© 2023 EpicentRx, Inc. All rights reserved.